Bioabsorbable Drug-Eluting Stents May Solve Lingering Thrombosis Problem
This article was originally published in The Pink Sheet Daily
Executive Summary
Bioabsorbable stents could reduce the risk of chronic inflammation and thrombosis associated with permanent implants, be better suited for pediatric applications, expert suggests at recent CRT conference. Boston Scientific/Riva Medical, Guidant, Biotronik and Biosensors all have bioabsorbable stent projects underway.
You may also be interested in...
Inner Glow Vitamins Launches Latest Sun Protection In A Pill
Sun protection is not an unheard-of claim in the dietary supplement space, but it has proven a problematic one from regulatory and legal standpoints.
Amyris Announces Gen Z-Focused EcoFabulous As Latest Acquisition In $12m Portfolio Enrichment
Brands under development and recent acquisitions including EcoFabulous, Costa Brazil and Terasana will account for around 20% of overall 2021 revenue in Amyris’ Consumer business, according to the firm, which aspires to be the “L’Oreal of clean beauty.”
J&J, Symrise Invest In Sunday II Sunday Hair Care For Active Women With Textured Hair
Johnson & Johnson Innovation led a $4.2m Series A financing announced on 25 March, which will help to build out Sunday II Sunday’s hair-care product offering and support in-store distribution in months to come.